Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 182

1.

Risk of venous thromboembolism and myocardial infarction associated with factor V Leiden and prothrombin mutations and blood type.

Sode BF, Allin KH, Dahl M, Gyntelberg F, Nordestgaard BG.

CMAJ. 2013 Mar 19;185(5):E229-37. doi: 10.1503/cmaj.121636. Epub 2013 Feb 4.

PMID:
23382263
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.

Miñano A, Ordóñez A, España F, González-Porras JR, Lecumberri R, Fontcuberta J, Llamas P, Marín F, Estellés A, Alberca I, Vicente V, Corral J.

Haematologica. 2008 May;93(5):729-34. doi: 10.3324/haematol.12271. Epub 2008 Apr 2.

PMID:
18387978
[PubMed - indexed for MEDLINE]
Free Article
3.

Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.

Lijfering WM, Middeldorp S, Veeger NJ, Hamulyák K, Prins MH, Büller HR, van der Meer J.

Circulation. 2010 Apr 20;121(15):1706-12. doi: 10.1161/CIRCULATIONAHA.109.906347. Epub 2010 Apr 5.

PMID:
20368522
[PubMed - indexed for MEDLINE]
Free Article
4.

[Factor V Leiden and prothrombin G20210A among Chilean patients with venous and arterial thrombosis].

Palomo I, Pereira J, Alarcón M, Pinochet C, Vélez MT, Hidalgo P, Skagerberg K, Poblete F.

Rev Med Chil. 2005 Dec;133(12):1425-33. Epub 2006 Jan 27. Spanish.

PMID:
16446869
[PubMed - indexed for MEDLINE]
Free Article
5.

The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.

De Stefano V, Martinelli I, Mannucci PM, Paciaroni K, Chiusolo P, Casorelli I, Rossi E, Leone G.

N Engl J Med. 1999 Sep 9;341(11):801-6.

PMID:
10477778
[PubMed - indexed for MEDLINE]
Free Article
6.

Influence of proband's characteristics on the risk for venous thromboembolism in relatives with factor V Leiden or prothrombin G20210A polymorphisms.

Bucciarelli P, De Stefano V, Passamonti SM, Tormene D, Legnani C, Rossi E, Castaman G, Simioni P, Cini M, Martinelli I.

Blood. 2013 Oct 10;122(15):2555-61. doi: 10.1182/blood-2013-05-503649. Epub 2013 Aug 2.

PMID:
23913469
[PubMed - indexed for MEDLINE]
7.

Type and location of venous thromboembolism in carriers of Factor V Leiden or prothrombin G20210A mutation versus patients with no mutation.

Kovac M, Mitic G, Mikovic Z, Antonijevic N, Djordjevic V, Mikovic D, Mandic V, Rakicevic L, Radojkovic D.

Clin Appl Thromb Hemost. 2010 Feb;16(1):66-70. doi: 10.1177/1076029608320721. Epub 2008 Sep 15.

PMID:
18796457
[PubMed - indexed for MEDLINE]
8.

Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review.

Segal JB, Brotman DJ, Necochea AJ, Emadi A, Samal L, Wilson LM, Crim MT, Bass EB.

JAMA. 2009 Jun 17;301(23):2472-85. doi: 10.1001/jama.2009.853. Review.

PMID:
19531787
[PubMed - indexed for MEDLINE]
9.

The O blood group protects against venous thromboembolism in individuals with the factor V Leiden but not the prothrombin (factor II G20210A) mutation.

González Ordóñez AJ, Medina Rodriguez JM, Martín L, Alvarez V, Coto E.

Blood Coagul Fibrinolysis. 1999 Jul;10(5):303-7.

PMID:
10456623
[PubMed - indexed for MEDLINE]
10.

G20210A mutation in the prothrombin gene and the risk of recurrent venous thromboembolism.

Miles JS, Miletich JP, Goldhaber SZ, Hennekens CH, Ridker PM.

J Am Coll Cardiol. 2001 Jan;37(1):215-8.

PMID:
11153741
[PubMed - indexed for MEDLINE]
Free Article
11.

The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or both.

Martinelli I, Bucciarelli P, Margaglione M, De Stefano V, Castaman G, Mannucci PM.

Br J Haematol. 2000 Dec;111(4):1223-9.

PMID:
11167765
[PubMed - indexed for MEDLINE]
12.

Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium.

Gerhardt A, Scharf RE, Beckmann MW, Struve S, Bender HG, Pillny M, Sandmann W, Zotz RB.

N Engl J Med. 2000 Feb 10;342(6):374-80.

PMID:
10666427
[PubMed - indexed for MEDLINE]
Free Article
13.

Type and location of venous thromboembolism in patients with factor V Leiden or prothrombin G20210A and in those with no thrombophilia.

Martinelli I, Battaglioli T, Razzari C, Mannucci PM.

J Thromb Haemost. 2007 Jan;5(1):98-101. Epub 2006 Oct 25.

PMID:
17067362
[PubMed - indexed for MEDLINE]
14.

Oral contraceptives, ABO blood types and thromboembolism.

Ambrus JL.

CMAJ. 2013 Nov 19;185(17):1526. doi: 10.1503/cmaj.113-2148. No abstract available.

PMID:
24247436
[PubMed - indexed for MEDLINE]
15.

Factors that predict risk of thrombosis in relatives of patients with unprovoked venous thromboembolism.

Couturaud F, Leroyer C, Julian JA, Kahn SR, Ginsberg JS, Wells PS, Douketis JD, Mottier D, Kearon C.

Chest. 2009 Dec;136(6):1537-45. doi: 10.1378/chest.09-0757. Epub 2009 Jul 10.

PMID:
19592474
[PubMed - indexed for MEDLINE]
16.

Prothrombin and risk of venous thromboembolism, ischemic heart disease and ischemic cerebrovascular disease in the general population.

Weischer M, Juul K, Zacho J, Jensen GB, Steffensen R, Schroeder TV, Tybjaerg-Hansen A, Nordestgaard BG.

Atherosclerosis. 2010 Feb;208(2):480-3. doi: 10.1016/j.atherosclerosis.2009.05.006. Epub 2009 May 21.

PMID:
19524925
[PubMed - indexed for MEDLINE]
17.

Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.

Emmerich J, Rosendaal FR, Cattaneo M, Margaglione M, De Stefano V, Cumming T, Arruda V, Hillarp A, Reny JL.

Thromb Haemost. 2001 Sep;86(3):809-16. Erratum in: Thromb Haemost 2001 Dec;86(6):1598.

PMID:
11583312
[PubMed - indexed for MEDLINE]
18.

Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.

Couturaud F, Duchemin J, Leroyer C, Delahousse B, Abgrall JF, Mottier D; Groupe d'Etude de la Thrombose de Bretagne Occidentale (G.E.T.B.O).

Thromb Haemost. 2008 Jan;99(1):223-8. doi: 10.1160/TH07-08-0515.

PMID:
18217158
[PubMed - indexed for MEDLINE]
19.

Prevalence of factor V G1691A (Leiden) and prothrombin G20210A polymorphisms among apparently healthy Jordanians.

Nusier MK, Radaideh AM, Ababneh NA, Qaqish BM, Alzoubi R, Khader Y, Mersa JY, Irshaid NM, El-Khateeb M.

Neuro Endocrinol Lett. 2007 Oct;28(5):699-703.

PMID:
17984931
[PubMed - indexed for MEDLINE]
20.

Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study.

Mueller T, Marschon R, Dieplinger B, Haidinger D, Gegenhuber A, Poelz W, Webersinke G, Haltmayer M.

J Vasc Surg. 2005 May;41(5):808-15.

PMID:
15886665
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk